EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rates of clinical remission and inadequate response to advanced therapies among patients with ulcerative colitis in Germany

Bernd Bokemeyer, Nils Picker, Daniel Kromer, Ludger Rosin, Haridarshan Patel

International Journal of Colorectal Disease · 2023

DOI: 10.1007/s00384-023-04397-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Colorectal Disease, 2023. Verfasst von Bernd Bokemeyer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Crohn Colitis Centre Minden, North Rhine-Westphalia, Märchenweg 17, 32429, Minden, Germany. bernd.bokemeyer@t-online.de. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Biological Products. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Galápagos.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Many patients treated for ulcerative colitis (UC) do not achieve clinical remission. This real-world study assessed clinical remission and inadequate response rates among patients with UC in Germany treated with advanced therapies.

Methods

This retrospective chart review included patients with UC newly initiating advanced (index) therapy (anti-TNFα agents, vedolizumab, tofacitinib) from January 2017–September 2019 (index date). Included patients had data for ≥ 12 months before (baseline period) and after the index date (follow-up period). Remission was defined as a partial Mayo score ≤ 1. Indicators of inadequate response were: index therapy discontinuation; therapy adjustments (index therapy dose escalation; augmentation with non-advanced therapies; corticosteroid [CS] use during maintenance therapy); CS dependency (use for ≥ 12 weeks); and UC-related hospitalisation, surgery or emergency department visit. Time to first remission and inadequate response were analyzed using Kaplan–Meier analyses.

Results

Among 149 patients with UC (median age: 40 years), 96 (64.4%) were biologic-naïve and 42 (28.2%) received CS at the index date. Within 12 months, 52 patients (47.2%) were in remission; of these, 13 patients (25.0%) received ≥ 1 therapy adjustment. At 12 months, 55 patients (37.6%) had ≥ 1 indicator of an inadequate response. Median time to remission was longer among biologic-experienced vs biologic-naïve patients (24 vs 7 months; p = 0.012).

Conclusion

Over half of the patients were not in clinical remission after 12 months and more than one-third experienced inadequate response. One-quarter of patients in remission required therapy adjustments. Patients with UC require therapies that are more effective than those currently available to achieve better treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeBiological ProductsHumansAdultRetrospective StudiesTreatment OutcomeRemission Induction

Stichwörter der Autor:innen

Advanced therapyInadequate responseReal-world treatmentUlcerative colitis

Substanzen

Biological Products

Autor:innen und Institutionen

  • Interdisciplinary Crohn Colitis Centre Minden, North Rhine-Westphalia, Märchenweg 17, 32429, Minden, Germany. bernd.bokemeyer@t-online.de.
  • Real World and Advanced Analytics, Ingress-Health HWM GmbH, Wismar, Mecklenburg-Vorpommern, Germany.
  • Medical Affairs, Galapagos Biopharma Deutschland GmbH, Munich, Bavaria, Germany.
  • Evidence Generation and Epidemiology, Medical Affairs, Galapagos NV, Mechelen, Antwerp, Belgium.

Förderung

  • Galápagos

Zitieren

APA

Bokemeyer, B., Picker, N., Kromer, D., Rosin, L., & Patel, H. (2023). Rates of clinical remission and inadequate response to advanced therapies among patients with ulcerative colitis in Germany. International Journal of Colorectal Disease. https://doi.org/10.1007/s00384-023-04397-7

Vancouver

Bokemeyer B, Picker N, Kromer D, Rosin L, Patel H. Rates of clinical remission and inadequate response to advanced therapies among patients with ulcerative colitis in Germany. International Journal of Colorectal Disease. 2023. doi:10.1007/s00384-023-04397-7

BibTeX
@article{Bokemeyer2023,
  author = {Bokemeyer, Bernd and Picker, Nils and Kromer, Daniel and Rosin, Ludger and Patel, Haridarshan},
  title = {Rates of clinical remission and inadequate response to advanced therapies among patients with ulcerative colitis in Germany},
  journal = {International Journal of Colorectal Disease},
  year = {2023},
  doi = {10.1007/s00384-023-04397-7}
}
Kostenlos starten →